Drug recall D-1037-2022
Product
Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton, Rx only, MFG: Avkare Inc., NDC 50268-523-15
Reason for recall
cGMP deviations: Temperature abuse
Lots and codes
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Recall details
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Quantity
- 1 box/50 blister packs per box
- Distribution
- USA nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 13, 2022
- Terminated
- November 30, 2023
Related products
- Meclizine Hydrochloride – drug information
- NDC 50268-523 Meclizine Hydrochloride · Meclizine Hydrochloride 25 mg/1 · AvPAK
- NDC 50268-522 Meclizine Hydrochloride · Meclizine Hydrochloride 12.5 mg/1 · AvPAK